Randomized Phase 2 Trial of Lirilumab as maintenance Treatment in Acute Myeloid Leukemia: Results of the EFFIKIR Trial
N. Vey, AS. Chretien, PY. Dumas, C. Recher, L. Gastaud, B. Lioure, CE. Bulabois, C. Pautas, JP. Marolleau, S. Lepretre, E. Raffoux, X. Thomas, Y. Hichri, C. Bonmati, B. Quesnel, P. Rousselot, E. Jourdan, JV. Malfuson, G. Guillerm, JH. Bourhis, M. Ojeda-Uribe, M. Hunault, A. Ben Amara, MS. Rouvière, N. Boucherit, P. André, C. Preudhomme, N. Dulphy, A. Toubert, N. Ifrah, D. Olive, H. Dombret
doi: https://doi.org/10.1101/2024.08.23.24312477
